Potential impact of missing outcome data on treatment effects in systematic reviews: imputation study

Abstract Objective To assess the risk of bias associated with missing outcome data in systematic reviews. Design Imputation study. Setting Systematic reviews. Population 100 systematic reviews that included a group level meta-analysis with a statistically significant effect on a patient important dichotomous efficacy outcome. Main outcome measures Median percentage change in the relative effect estimate when applying each of the following assumption (four commonly discussed but implausible assumptions (best case scenario, none had the event, all had the event, and worst case scenario) and four plausible assumptions for missing data based on the informative missingness odds ratio (IMOR) approach (IMOR 1.5 (least stringent), IMOR 2, IMOR 3, IMOR 5 (most stringent)); percentage of meta-analyses that crossed the threshold of the null effect for each method; and percentage of meta-analyses that qualitatively changed direction of effect for each method. Sensitivity analyses based on the eight different methods of handling missing data were conducted. Results 100 systematic reviews with 653 randomised controlled trials were included. When applying the implausible but commonly discussed assumptions, the median change in the relative effect estimate varied from 0% to 30.4%. The percentage of meta-analyses crossing the threshold of the null effect varied from 1% (best case scenario) to 60% (worst case scenario), and 26% changed direction with the worst case scenario. When applying the plausible assumptions, the median percentage change in relative effect estimate varied from 1.4% to 7.0%. The percentage of meta-analyses crossing the threshold of the null effect varied from 6% (IMOR 1.5) to 22% (IMOR 5) of meta-analyses, and 2% changed direction with the most stringent (IMOR 5). Conclusion Even when applying plausible assumptions to the outcomes of participants with definite missing data, the average change in pooled relative effect estimate is substantive, and almost a quarter (22%) of meta-analyses crossed the threshold of the null effect. Systematic review authors should present the potential impact of missing outcome data on their effect estimates and use this to inform their overall GRADE (grading of recommendations assessment, development, and evaluation) ratings of risk of bias and their interpretation of the results.

[1]  Lara A Kahale,et al.  A guidance was developed to identify participants with missing outcome data in randomized controlled trials. , 2019, Journal of clinical epidemiology.

[2]  Dimitris Mavridis,et al.  Dealing with missing outcome data in meta‐analysis , 2019, Research synthesis methods.

[3]  Loukia M Spineli,et al.  An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis , 2019, BMC Medical Research Methodology.

[4]  L. Puljak,et al.  Assessments of attrition bias in Cochrane systematic reviews are highly inconsistent and thus hindering trial comparability , 2019, BMC Medical Research Methodology.

[5]  N. Lazar,et al.  Moving to a World Beyond “p < 0.05” , 2019, The American Statistician.

[6]  Lara A. Kahale,et al.  Potentially missing data are considerably more frequent than definitely missing data: a methodological survey of 638 randomized controlled trials. , 2019, Journal of clinical epidemiology.

[7]  Dimitris Mavridis,et al.  Allowing for Informative Missingness in Aggregate Data Meta-Analysis with Continuous or Binary Outcomes: Extensions to Metamiss , 2018, The Stata journal.

[8]  G. O'Reilly,et al.  Missing data in trauma registries: A systematic review. , 2018, Injury.

[9]  Lara A. Kahale,et al.  Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey. , 2018, Journal of clinical epidemiology.

[10]  J. Carpenter,et al.  Missing data in clinical research: an integrated approach , 2017, The British journal of dermatology.

[11]  Lara A. Kahale,et al.  GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence. , 2017, Journal of clinical epidemiology.

[12]  David C. Currow,et al.  Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review , 2017, Journal of clinical epidemiology.

[13]  Katherine J. Lee,et al.  Treatment of missing data in follow-up studies of randomised controlled trials: A systematic review of the literature , 2017, Clinical trials.

[14]  C. Ramsay,et al.  Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade? , 2016, Quality of Life Research.

[15]  Lara A Kahale,et al.  Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers. , 2016, Journal of clinical epidemiology.

[16]  Kevin A. Hallgren,et al.  Missing Data in Alcohol Clinical Trials with Binary Outcomes. , 2016, Alcoholism, clinical and experimental research.

[17]  B. Tom,et al.  A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes , 2016, Trials.

[18]  Lara A Kahale,et al.  Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide , 2015, BMJ Open.

[19]  Thomas Agoritsas,et al.  Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches , 2015, Systematic Reviews.

[20]  Lara A. Kahale,et al.  Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study , 2014, Systematic Reviews.

[21]  Melanie L Bell,et al.  Handling missing data in RCTs; a review of the top medical journals , 2014, BMC Medical Research Methodology.

[22]  Paula Williamson,et al.  A review of the handling of missing longitudinal outcome data in clinical trials , 2014, Trials.

[23]  Gordon H Guyatt,et al.  Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers. , 2014, Journal of clinical epidemiology.

[24]  Xin Sun,et al.  Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. , 2013, Journal of clinical epidemiology.

[25]  R. Little,et al.  The design and conduct of clinical trials to limit missing data , 2012, Statistics in medicine.

[26]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[27]  Gordon H Guyatt,et al.  Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review , 2012, BMJ : British Medical Journal.

[28]  J. Higgins Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[29]  Nneka Emenyonu,et al.  Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach , 2010, Journal of acquired immune deficiency syndromes.

[30]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[31]  I. White,et al.  Meta-analysis with Missing Data , 2009 .

[32]  Jeffrey N. Martin,et al.  Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. , 2008, JAMA.

[33]  Ian R White,et al.  Imputation methods for missing outcome data in meta-analysis of clinical trials , 2008, Clinical trials.

[34]  Nicky J Welton,et al.  Allowing for uncertainty due to missing data in meta‐analysis—Part 2: Hierarchical models , 2008, Statistics in medicine.

[35]  Ian R White,et al.  Allowing for uncertainty due to missing data in meta‐analysis—Part 1: Two‐stage methods , 2008, Statistics in medicine.

[36]  Carrol Gamble,et al.  Uncertainty method improved on best-worst case analysis in a binary meta-analysis. , 2005, Journal of clinical epidemiology.

[37]  D. Sackett,et al.  Cochrane Collaboration , 1994, BMJ.